Omega-3 fatty acids and supportive psychotherapy for perinatal depression: A randomized placebo-controlled study

Journal of Affective Disorders

Volumn 110, Issue 1-2, 2008, Pages 142-148

  Freeman, Marlene P ^a,b   Davis, Melinda ^b   Sinha, Priti ^b   Wisner, Katherine L ^c   Hibbeln, Joseph R ^d   Gelenberg, Alan J ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d National Institute for Alcohol Abuse and Alcoholism   (United States)

Author keywords

Depression; Omega 3; Perinatal; Postpartum; Pregnancy; Supportive psychotherapy

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PLACEBO;

ADULT; ARTICLE; BURPING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDINBURGH POSTNATAL DEPRESSION SCALE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HALITOSIS; HAMILTON SCALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; NAUSEA; PERINATAL PERIOD; PRIORITY JOURNAL; PSYCHOTHERAPY; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TASTE DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; UNPLEASANT BREATH; UNPLEASANT TASTE;

COMBINED MODALITY THERAPY; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, MAJOR; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFANT; PLACEBOS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTHERAPY; PSYCHOTHERAPY, BRIEF; PUERPERAL DISORDERS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 44849122926     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.12.228     Document Type: Article

References (40)

1. Al M.D., Van Houwelingen A.C., Kester A.D.M., Hasaart T.H.M., De Jong A.E.P., and Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 74 (1995) 55-68
2. Alwan S., Reefhuis J., Rasmussen S.A., Olney R., and Friedman J.M. Use of selective serotonin reuptake inhibitors in pregnancy and the risk of birth defects. N. Engl. J. Med. 356 (2007) 2684-2692
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (1994), American Psychiatric Association, Washington, DC
4. Appleby L., Warner R., Whitton A., and Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. Br. Med. J. 314 (1997) 932-939
5. Benisek D., Shabert J., and Skornik R. Dietary intake of polyunsaturated fatty acids by pregnant or lactating women in the United States. Obstet. Gynecol. 95 (2000) 77-78
6. Brent D.A., and Kolko D.J. Supportive Relationship Treatment Manual (Non-Directive Therapy, NST), (Revisions Made by Elizabeth Perkins, M.S.W., Carl Bonner, M.A. and Susan Hogarty, R.N., 1991) (1989)
7. Carlson S.E. Docosahexaenoic acid and arachidonic acid in infant development. Semin. Neonatol. 6 5 (2001) 437-449
8. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., Werler M.M., Louik C., Jones K.L., and Mitchell A.A. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 354 6 (2006) 579-587
9. Cohen L.S., Altshuler L.L., Harlow B.L., Nonacs R., Newport D.J., Viguera A.C., Suri R., Burt V.K., Hendrick V., Remnick A.M., Loughead A., Vitonis A.F., and Stowe Z.N. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 5 (2006) 499-507
10. Cox J.L., Holden J.M., and Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh postnatal depression scale. Br. J. Psychiatry (1987) 782-786
11. Dennis C.L. Treatment of postpartum depression, part 2: a critical review of nonbiological interventions. J. Clin. Psychiatry 65 9 (2004) 1252-1265
12. Dec. 21. Dunstan J.A., Simmer K., Dixon G., and Prescott S.L. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child., Fetal Neonatal Ed. 93 1 (2008) F45-50
13. Evans J., Heron J., Francomb H., Oke S., and Golding J. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323 (2001) 257-260
14. Foran S.E., Flood J.G., and Lewandrowski K.B. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?. Arch. Pathol. Lab. Med. 127 12 (2003) 1603-1605
15. Freeman M.P., and Sinha P. Tolerability of omega-3 Fatty acid supplements in perinatal women. Prostaglandins, Leukotriones, and Essential Fatty Acids 77 (2007) 203-208
16. Freeman M.P., Hibbeln J.R., Wisner K.L., Brumbach B.H., Watchman W., and Gelenberg A.J. Randomized dose-ranging pilot trial of omega-3 fatty acids for postnatal depression. Acta Psychiatr. Scand. 113 1 (2006) 31-35
17. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck P.E., Marangell L.B., Richardson A.J., Lake J., and Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry [American Psychiatric Association Subcommittee Report]. J. Clin. Psychiatry 67 (2006) 1954-1967
18. Freeman M.P., Hibbeln J.R., Wisner K.L., Watchman M., and Gelenberg A.J. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatr. 18 (2006) 21-24
19. Guy W. ECDEU Assessment Manual for Psychopharmacology. DHEW Publication No. (ADM) 76-338 (1976), National Institute of Mental Health, Rockville, MD
20. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69 1-3 (2002) 15-29
21. Hibbeln J.R., Davis J.M., Steer C., Emmett P., Rogers I., Williams C., and Golding J. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369 (2007) 578-585. http://www.fda.gov/bbs/topics/news/2004/NEW01038.html http://www.fda.gov/bbs/topics/news/2004/NEW01038.html
22. Istvan J. Stress, anxiety, and birth outcomes: a critical review of the evidence. Psychol. Bull. 100 (1986) 331-348
23. Kris-Etherton P.M., Harris W.S., and Appel L.J. AHA Nutrition Committee, American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler. Thromb. Vasc. Biol. 23 2 (2003) 151-152
24. Levant B., Radel J.D., and Carlson S.E. Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids. Biol. Psychiatry 60 9 (2006) 987-990
25. Louik C., Lin A.E., Werler M.M., Hernandez-Diaz S., and Mitchell A.A. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N. Engl. J. Med. 356 (2007) 2675-2683
26. Marcus S.M., Flynn H.A., Blow F.C., and Barry K.L. Depressive symptoms among pregnant women screened in obstetrics settings. J. Women's Health 12 4 (2003) 373-380
27. McGregor J.A., Allen K.G., Harris M.A., Peece M., Wheeler M., French J.I., and Morrison J. The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomes. Obstet. Gynecol. Surv. 56 5 Suppl 1 (2001) S1-S13
28. Min Y., Ghebremeskel K., Crawford M.A., Nam J.H., Kim A., Koo J.N., and Suzuki H. Pregnancy reduces arachidonic and docosahexaenoic in plasma triacylglycerols of Korean women. Int. J. Vitam. Nutr. Res. 70 (2000) 70-75
29. Moses-Kolko E.L., Bogen D., Perel J., Bregar A., Uhl K., Levin B., and Wisner K.L. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 19 (2005) 2372-2383
30. Newport D.J., Wilcox M.M., and Stowe Z.N. Maternal depression: a child's first adverse life event. Semin. Clin. Neuropsychiatry 7 2 (2002) 113-119
31. Oken E., Kleinman K.P., Berland W.E., Simon S.R., Rich-Edwards J.W., and Gillman M.W. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet. Gynecol. 102 2 (2003) 346-351
32. Oken E., Wright R.O., Kleinman K.P., Bellinger D., Amarasiriwardena C.J., Hu H., Rich-Edwards J.W., and Gillman M.W. Maternal fish consumption, hair mercury, and infant cognition in a U.S. cohort. Environ. Health Perspect. 113 10 (2005) 1376-1380
33. Otto S.J., Van Houwelingen A.C., Antal M., Manninen A., Godfrey K., Lopez-Jaramillo P., and Hornstra G. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur. J. Clin. Nutr. 51 (1997) 232-242
34. Parker G., Gibson N.A., Brotchie H., Heruc G., Rees A.M., and Hadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am. J. Psychiatry 163 6 (2006) 969-978
35. Stuart S., O'Hara M.W., and Gorman L.L. The prevention and psychotherapeutic treatment of postpartum depression. Arch. Women Ment. Health 6 Suppl 2 (2003) S57-S69
36. Wadhwa P.D., Sandman C.A., Porto M., Dunkel-Schetter C., and Garite T.J. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am. J. Obstet. Gynecol. 169 (1993) 858-865
37. Weissman A.M., Levy B.T., Hartz A.J., Bentler S., Donohue M., Ellingrod V.L., and Wisner K.L. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am. J. Psychiatry 161 6 (2004) 1066-1078
38. *D-child report. JAMA 295 12 (2006) 1389-1398
39. Wisner K.L., Zarin D.A., Holmboe E.S., Appelbaum P.S., Gelenberg A.J., Leonard H.L., and Frank E. Risk-benefit decision making for treatment of depression during pregnancy. Am. J. Psychiatry 157 (2000) 1933-1940
40. Wisner K.L., Hanusa B.H., Perel J.M., Peindl K.S., Piontek C.M., Findling R.L., and Moses-Kolko E.L. Postpartum depression: a randomized trial of sertraline versus nortriptyline. J. Clin. Psychopharmacol. 26 4 (2006) 353-360